2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride

C78H87Cl3F6N8O10Si — CID 159119903

IUPAC2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride
SMILESCC(=O)c1cn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)[C@H](C)CO)c2ccc(CC(=O)N3CCCC(F)(F)C3)cc12.CC(=O)c1cn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)[C@H](C)CO[Si](C)(C)C(C)(C)C)c2ccc(CC(=O)N3CCCC(F)(F)C3)cc12.Cl
InChIInChI=1S/C42H50ClF3N4O5Si.C36H36ClF3N4O5.ClH/c1-27(25-55-56(6,7)41(3,4)5)50(23-37(52)47-35-15-10-13-31(40(35)44)30-12-8-9-14-34(30)43)39(54)24-49-22-33(28(2)51)32-20-29(16-17-36(32)49)21-38(53)48-19-11-18-42(45,46)26-48;1-22(20-45)44(18-32(47)41-30-10-5-8-26(35(30)38)25-7-3-4-9-29(25)37)34(49)19-43-17-28(23(2)46)27-15-24(11-12-31(27)43)16-33(48)42-14-6-13-36(39,40)21-42;/h8-10,12-17,20,22,27H,11,18-19,21,23-26H2,1-7H3,(H,47,52);3-5,7-12,15,17,22,45H,6,13-14,16,18-21H2,1-2H3,(H,41,47);1H/t27-;22-;/m11./s1
InChIKeyPDQQEXVEOYTFHW-XOLVUXOVSA-N
MW1545.03 g/mol
LogP15.35
Rot. Bonds24

About 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride

2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride (PubChem CID 159119903) has the molecular formula C78H87Cl3F6N8O10Si and a molecular weight of 1545.03 g/mol. Its IUPAC name is 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride.

Molecular Properties

Compound Name2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride
PubChem CID159119903
Molecular FormulaC78H87Cl3F6N8O10Si
Molecular Weight1545.03 g/mol
Exact Mass1542.53
IUPAC Name2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride
SMILESCC(=O)c1cn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)[C@H](C)CO)c2ccc(CC(=O)N3CCCC(F)(F)C3)cc12.CC(=O)c1cn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)[C@H](C)CO[Si](C)(C)C(C)(C)C)c2ccc(CC(=O)N3CCCC(F)(F)C3)cc12.Cl
InChIInChI=1S/C42H50ClF3N4O5Si.C36H36ClF3N4O5.ClH/c1-27(25-55-56(6,7)41(3,4)5)50(23-37(52)47-35-15-10-13-31(40(35)44)30-12-8-9-14-34(30)43)39(54)24-49-22-33(28(2)51)32-20-29(16-17-36(32)49)21-38(53)48-19-11-18-42(45,46)26-48;1-22(20-45)44(18-32(47)41-30-10-5-8-26(35(30)38)25-7-3-4-9-29(25)37)34(49)19-43-17-28(23(2)46)27-15-24(11-12-31(27)43)16-33(48)42-14-6-13-36(39,40)21-42;/h8-10,12-17,20,22,27H,11,18-19,21,23-26H2,1-7H3,(H,47,52);3-5,7-12,15,17,22,45H,6,13-14,16,18-21H2,1-2H3,(H,41,47);1H/t27-;22-;/m11./s1
InChIKeyPDQQEXVEOYTFHW-XOLVUXOVSA-N
XLogP15.35
TPSA212.90 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds24
Heavy Atoms106
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001545.03
LogP ≤ 515.35
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride?
The IUPAC name of 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride (CID 159119903) is 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride.
What is the SMILES notation for 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride?
The canonical SMILES for 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride is CC(=O)c1cn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)[C@H](C)CO)c2ccc(CC(=O)N3CCCC(F)(F)C3)cc12.CC(=O)c1cn(CC(=O)N(CC(=O)Nc2cccc(-c3ccccc3Cl)c2F)[C@H](C)CO[Si](C)(C)C(C)(C)C)c2ccc(CC(=O)N3CCCC(F)(F)C3)cc12.Cl.
What is the InChIKey of 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride?
The InChIKey is PDQQEXVEOYTFHW-XOLVUXOVSA-N. The full InChI is InChI=1S/C42H50ClF3N4O5Si.C36H36ClF3N4O5.ClH/c1-27(25-55-56(6,7)41(3,4)5)50(23-37(52)47-35-15-10-13-31(40(35)44)30-12-8-9-14-34(30)43)39(54)24-49-22-33(28(2)51)32-20-29(16-17-36(32)49)21-38(53)48-19-11-18-42(45,46)26-48;1-22(20-45)44(18-32(47)41-30-10-5-8-26(35(30)38)25-7-3-4-9-29(25)37)34(49)19-43-17-28(23(2)46)27-15-24(11-12-31(27)43)16-33(48)42-14-6-13-36(39,40)21-42;/h8-10,12-17,20,22,27H,11,18-19,21,23-26H2,1-7H3,(H,47,52);3-5,7-12,15,17,22,45H,6,13-14,16,18-21H2,1-2H3,(H,41,47);1H/t27-;22-;/m11./s1.
What are the key properties of 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride?
2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride has a molecular weight of 1545.03 g/mol, XLogP of 15.35, 24 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[(2R)-1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]acetamide;2-[3-acetyl-5-[2-(3,3-difluoropiperidin-1-yl)-2-oxoethyl]indol-1-yl]-N-[2-[3-(2-chlorophenyl)-2-fluoroanilino]-2-oxoethyl]-N-[(2R)-1-hydroxypropan-2-yl]acetamide;hydrochloride is sourced from PubChem (CID 159119903), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).